- Home
- ILMN vs CBOE Comparison
ILMN vs CBOE Comparison
Compare ILMN & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- CBOE
- Stock Information
- Founded
- ILMN 1998
- CBOE 1973
- Country
- ILMN United States
- CBOE United States
- Employees
- ILMN N/A
- CBOE N/A
- Industry
- ILMN Medical Specialities
- CBOE Investment Bankers/Brokers/Service
- Sector
- ILMN Health Care
- CBOE Finance
- Exchange
- ILMN Nasdaq
- CBOE Nasdaq
- Market Cap
- ILMN 15.3B
- CBOE 25.6B
- IPO Year
- ILMN 2000
- CBOE 2010
- Fundamental
- Price
- ILMN $92.21
- CBOE $239.07
- Analyst Decision
- ILMN Buy
- CBOE Hold
- Analyst Count
- ILMN 15
- CBOE 13
- Target Price
- ILMN $124.27
- CBOE $234.15
- AVG Volume (30 Days)
- ILMN 1.7M
- CBOE 789.6K
- Earning Date
- ILMN 11-03-2025
- CBOE 10-31-2025
- Dividend Yield
- ILMN N/A
- CBOE 1.21%
- EPS Growth
- ILMN N/A
- CBOE 18.01
- EPS
- ILMN 7.91
- CBOE 8.52
- Revenue
- ILMN $4,284,000,000.00
- CBOE $4,531,800,000.00
- Revenue This Year
- ILMN N/A
- CBOE N/A
- Revenue Next Year
- ILMN $2.74
- CBOE $4.38
- P/E Ratio
- ILMN $11.54
- CBOE $27.96
- Revenue Growth
- ILMN N/A
- CBOE 18.98
- 52 Week Low
- ILMN $68.70
- CBOE $187.30
- 52 Week High
- ILMN $156.66
- CBOE $255.27
- Technical
- Relative Strength Index (RSI)
- ILMN 42.07
- CBOE 47.30
- Support Level
- ILMN $88.00
- CBOE $234.72
- Resistance Level
- ILMN $98.70
- CBOE $246.64
- Average True Range (ATR)
- ILMN 3.63
- CBOE 4.66
- MACD
- ILMN -0.65
- CBOE -0.07
- Stochastic Oscillator
- ILMN 28.03
- CBOE 30.48
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.